Literature DB >> 2206264

Longitudinal cognitive decline in patients with Alzheimer's disease.

G Rebok1, J Brandt, M Folstein.   

Abstract

Progressive cognitive impairment is a defining feature of the dementia of Alzheimer's disease (AD), yet disagreement exists over which abilities decline most precipitously and which cognitive tests are more sensitive. In this study, 51 AD patients in the early to middle stages of illness and 22 age-matched normal controls were administered a battery of neuropsychological tests at 6-month intervals over a 2-year period. While the performance of the normal controls remained stable over the 2 years, the AD patients displayed progressive decline on all tests. The greatest declines occurred on tests requiring lexical/semantic processing (Boston Naming Test) and comprehension of syntactic relationships (Token Test). Performance on visuospatial tests (Wechsler Adult Intelligence Scale-Revised Block Design, Benton Visual Retention Test, Spatial Delayed Recognition Span Test) declined less rapidly. The findings support previous reports that language impairment may be central to the dementia of AD, and that confrontation naming is particularly sensitive to decline in this illness.

Entities:  

Mesh:

Year:  1990        PMID: 2206264     DOI: 10.1177/089198879000300207

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  6 in total

1.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

2.  Validation and diagnostic accuracy of predictive curves for age-associated longitudinal cognitive decline in older adults.

Authors:  Patrick J Bernier; Christian Gourdeau; Pierre-Hugues Carmichael; Jean-Pierre Beauchemin; René Verreault; Rémi W Bouchard; Edeltraut Kröger; Robert Laforce
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

3.  Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.

Authors:  Matthew R Woodward; Michael G Dwyer; Niels Bergsland; Jesper Hagemeier; Robert Zivadinov; Ralph Hb Benedict; Kinga Szigeti
Journal:  Psychiatry Res Neuroimaging       Date:  2017-06-09       Impact factor: 2.376

4.  Evaluation of a home-based exercise program in the treatment of Alzheimer's disease: the Maximizing Independence in Dementia (MIND) study.

Authors:  Martin Steinberg; Jeannie-Marie Sheppard Leoutsakos; Laura Jean Podewils; C G Lyketsos
Journal:  Int J Geriatr Psychiatry       Date:  2009-07       Impact factor: 3.485

5.  Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease.

Authors:  V Polo; E Garcia-Martin; M P Bambo; J Pinilla; J M Larrosa; M Satue; S Otin; L E Pablo
Journal:  Eye (Lond)       Date:  2014-03-14       Impact factor: 3.775

6.  Memory mood congruency phenomenon in bipolar I disorder and major depression disorder patients.

Authors:  V B Delgado; F Kapczinski; M L F Chaves
Journal:  Braz J Med Biol Res       Date:  2012-06-21       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.